Status:
WITHDRAWN
Optical Coherence Tomography Guided C&D
Lead Sponsor:
University of Miami
Conditions:
Basal Cell Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to identify the presence of residual superficial and nodular basal cell carcinoma (BCC) status-post curettage and desiccation (C\&D) by using optical coherence tomography (...
Eligibility Criteria
Inclusion
- Patients of any: age, gender, Fitzpatrick skin type and ethnicity.
- Primary BCC of any type, except aggressive types that fit the criteria for Mohs surgery
- No prior treatment on the lesion within the last 3 months.
- Lesions anywhere except the head, neck and distal extremities.
- Willing and able to sign informed consent
Exclusion
- Aggressive BCC types.
- Recurrent tumors.
- Lesion treated within last 3 months.
- Lesions on head and neck (high risk areas)
- Lesions on distal extremities (thin epidermis not preferred for OCT).
- Pregnant women.
- Patients less than 18 years old.
- Prisoners.
- Any other condition or circumstance that, in the opinion of the Investigator, may compromise the subject's ability to comply with the study protocol
Key Trial Info
Start Date :
April 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04510727
Start Date
April 1 2024
End Date
February 1 2025
Last Update
February 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maria V Muniz
Miami, Florida, United States, 33125